Download the programme (PDF)
08.30 – 09.00
Registration and coffee
09.00 - 09.05
Welcome & introduction
Professor David Taylor (chair), University College London
09.05 - 09.30
Keynote
Introduction by David MacMurchy, EY
A European perspective on MEAs
Alessandra Ferrario and Panos Kanavos, London School of Economics and Political Science
Session 1
Lessons from implementing MEAs – Part 1
09.30 - 09.50
Improving rational drug use through monitoring registries
Paolo Siviero, AIFA, Italy
09.50 - 10.10
New developments in the Polish risk-sharing landscape
Jakub Adamski, Polish Ministry of Health
10.10 - 10.30
Progress of the risk sharing scheme in providing MS drugs cost-effectively
Jackie Palace, Oxford University
10.30 - 10.50
Discussion
10.50 - 11.10
Coffee Break
Session 2
Lessons from implementing MEAs - Part 2
11.10 - 11.30
The ability of coverage with evidence development and to address uncertainties and improve performance in drug use
Karl Arnberg, TLV, Sweden
11.30 - 11.50
Results from the first re-assessments of coverage with evidence development schemes (CED): Is CED the way forward to introduce new and high cost medicines?
Caroline van der Meijden, CVZ, the Netherlands
11.50 - 12.10
Discussion
12.10 - 13.10
Lunch
Session 3
Stakeholder perspectives on MEAs
13.10 - 13.30
A manufacturer’s perspective on MEAs and their ability to improve access to medicines
Christophe Carbonel, Novartis
13.30-13.50
Can MEAs help us move towards a value-based pricing model?
Valerie Paris, OECD
13.50-14.10
Discussion
14.10-14.30
Coffee Break
14.30-15.00
Communicating value: The benefits of collaborative negotiation
Charles Barker, PrimeMover Associates LLC
15.00-15.20
Coffee Break
Session 4
The value of collecting additional evidence to improve decision-making – current reflections and future options
15.20 - 16.45
Panel
Chair: Panos Kanavos
Panellists:
Karl Arnberg, TLV, Sweden
Salvatore D’Acunto, EU Commission
Ansgar Hebborn, Roche
Caroline van der Meijden, CVZ, the Netherlands
Jean Mossman, European Brain Council
Silvia Ondategui-Parra, EY
Valerie Paris, OECD
Paolo Siviero, AIFA, Italy
Andrew Stainthorpe, NICE
16.45 - 17.00
Conclusions and farewell
Panos Kanavos and David Taylor